The 'pill penalty,' an unintended consequence of the IRA, has led to a disparity in investment for research and development ...

Successfully eliminating the so-called pill penalty faces an uphill battle, whether it’s attempted through executive changes ...

What if doctors could guide life-saving treatments through the body using only a magnet? An interdisciplinary collaboration ...

With the rapidly evolving regulatory landscape, staying on top of the latest updates is crucial for companies in biopharma and medical devices.

A contentious provision in President Biden's Inflation Reduction Act is under fire for stifling innovation in small-molecule ...

A controversial provision within President Joe Biden's Inflation Reduction Act (IRA) is drawing growing backlash from ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

The Trump Administration has the big-picture thinking to ‘Make America Healthy Again.’ That should start by eliminating ...

Department of Justice lawyer Jane Lyons urged the court to “slow down a little bit.” She said the White House’s policy had only been in place for three days, and McFadden’s injunction for ...

Trump’s Health Under Scrutiny Again: What Is White House Hiding About ... (Pic courtesy: iStock) Lilly’s experimental pill, orforglipron, is the first oral small-molecule GLP-1 receptor ...

Analysts expect the white-hot obesity ... is a small molecule, therefore Lilly’s drug could be absorbed more quickly than Rybelsus. People taking the semaglutide pill Rybelsus also have some ...

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill. The ACHIEVE-1 trial ...